Physician

Andrew S. Artz, M.D., M.S.

According to 2025 Medicare claims, Andrew Artz, M.D., M.S. (NPI: 1306859772) practices hematology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is CITY OF HOPE MEDICAL FOUNDATION (NPI: 1871886366; TIN: 274803222) and primary practice location at 91010-3012. Artz is affiliated with the UCMCNACO, LLC (ACO ID: A3531), participating under the MSSP model.

Artz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 185 traditional Medicare patients, billed 1,084 HCPCS/CPT codes, and received $105,419 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 217 prescription claims across 34 beneficiaries totaling $597,534 in drug costs, led by Jakafi (Ruxolitinib Phosphate). 2023 DME data shows 22 claims. Open Payments data shows 4 records totaling $11,002. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $42,106 to $105,419. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $494,122 and ending at $597,534. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.